MindMed Announces New Employee Inducement Grant
NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to thre
(Financial Post, 2025-11-03T21:12:08Z)